Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001599298-24-000117
Filing Date
2024-08-06
Accepted
2024-08-06 07:37:21
Documents
103
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q smmt-20240630.htm   iXBRL 10-Q 996448
2 EX-10.4 summit-akesoxamendment2t.htm EX-10.4 19015
3 EX-10.5 a2024-06x24subleasexdugg.htm EX-10.5 20475
4 EX-10.6 a2024-06x24subleasexgeni.htm EX-10.6 20427
5 EX-10.7 amd3tosublease-for10xqwi.htm EX-10.7 6692
6 EX-31.1 sum-ex311_20240630xduggan.htm EX-31.1 11818
7 EX-31.2 sum-ex312_20240630xzanganeh.htm EX-31.2 11900
8 EX-31.3 sum-ex313_20240630x10qsoni.htm EX-31.3 11927
9 EX-32.1 sum-ex321_20240630x10q.htm EX-32.1 11119
15 a2024-06x24subleasexdugg001.jpg GRAPHIC 253779
16 a2024-06x24subleasexdugg002.jpg GRAPHIC 202832
17 a2024-06x24subleasexdugg003.jpg GRAPHIC 274981
18 a2024-06x24subleasexdugg004.jpg GRAPHIC 216393
19 a2024-06x24subleasexdugg005.jpg GRAPHIC 261455
20 a2024-06x24subleasexdugg006.jpg GRAPHIC 163561
21 a2024-06x24subleasexdugg007.jpg GRAPHIC 70353
22 a2024-06x24subleasexgeni001.jpg GRAPHIC 262382
23 a2024-06x24subleasexgeni002.jpg GRAPHIC 212971
24 a2024-06x24subleasexgeni003.jpg GRAPHIC 257115
25 a2024-06x24subleasexgeni004.jpg GRAPHIC 216354
26 a2024-06x24subleasexgeni005.jpg GRAPHIC 261475
27 a2024-06x24subleasexgeni006.jpg GRAPHIC 163550
28 a2024-06x24subleasexgeni007.jpg GRAPHIC 68129
29 amd3tosublease-for10xqwi001.jpg GRAPHIC 243812
30 amd3tosublease-for10xqwi002.jpg GRAPHIC 174068
31 amd3tosublease-for10xqwi003.jpg GRAPHIC 50953
32 smmt-20240630_g1.jpg GRAPHIC 18976
33 smmt-20240630_g2.jpg GRAPHIC 40420
34 summit-akesoxamendment2t001.jpg GRAPHIC 218933
35 summit-akesoxamendment2t002.jpg GRAPHIC 229016
36 summit-akesoxamendment2t003.jpg GRAPHIC 235356
37 summit-akesoxamendment2t004.jpg GRAPHIC 248958
38 summit-akesoxamendment2t005.jpg GRAPHIC 249554
39 summit-akesoxamendment2t006.jpg GRAPHIC 64905
40 summit-akesoxamendment2t007.jpg GRAPHIC 49126
41 summit-akesoxamendment2t008.jpg GRAPHIC 23528
  Complete submission text file 0001599298-24-000117.txt   12280103

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20240630.xsd EX-101.SCH 49273
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT smmt-20240630_cal.xml EX-101.CAL 59455
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20240630_def.xml EX-101.DEF 180343
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20240630_lab.xml EX-101.LAB 484862
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20240630_pre.xml EX-101.PRE 351692
106 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20240630_htm.xml XML 669726
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 650-460-8308
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36866 | Film No.: 241177128
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)